The role of gemcitabine-docetaxel in the management of NMIBC: a scoping review of current status and future directions.

INTRODUCTION: Intravesical sequential gemcitabine - docetaxel (Gem/Doce) has emerged as an important chemotherapeutic regimen in the management of non - muscle-invasive bladder cancer (NMIBC). It holds particular clinical significance in the context…

Preview only. Read the full abstract at the source